WS #11093

From 500 msgs · 10 key-dev

Allegiant Travel raises Q2 guidance; Concentrix drops 15% on cut outlook; AMD hits 52-week high; Intel reclaims $140; AeroVironment Q4 blowout lifts drone stocks; FDA clears Zyn for reduced-risk claims. Anthropic launches Claude Science; Schneider Electric to buy Cognite for $3.1B; OpenAI introduces GeneBench-Pro.

Corporate earnings and analyst actions

Allegiant Travel raises Q2 guidance; Concentrix drops 15% on cut outlook; AMD hits 52-week high; Intel reclaims $140; AeroVironment Q4 blowout lifts drone stocks; FDA clears Zyn for reduced-risk claims.

Anthropic launches Claude Science; Schneider Electric to buy Cognite for $3.1B; OpenAI introduces GeneBench-Pro.

Full world state #11093 →

Corporate earnings and analyst actions — World state #11093 · River